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Abstract
Background: Hypoglossal (XII) motoneurons innervate tongue muscles and are vital for maintaining upper-airway patency
during inspiration. Depression of XII nerve activity by opioid analgesics is a significant clinical problem, but underlying
mechanisms are poorly understood. Currently there are no suitable pharmacological approaches to counter opiate-induced
suppression of XII nerve activity while maintaining analgesia. Ampakines accentuate a-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate (AMPA) receptor responses. The AMPA family of glutamate receptors mediate excitatory transmission
to XII motoneurons. Therefore the objectives were to determine whether the depressant actions of m-opioid receptor
activation on inspiratory activity includes a direct inhibitory action at the inspiratory premotoneuron to XII motoneuron
synapse, and to identify underlying mechanism(s). We then examined whether ampakines counteract opioid-induced
depression of XII motoneuron activity.
Methodology/Principal Findings: A medullary slice preparation from neonatal rat that produces inspiratory-related output
in vitro was used. Measurements of inspiratory burst amplitude and frequency were made from XII nerve roots. Whole-cell
patch recordings from XII motoneurons were used to measure membrane currents and synaptic events. Application of the
m-opioid receptor agonist, DAMGO, to the XII nucleus depressed the output of inspiratory XII motoneurons via presynaptic
inhibition of excitatory glutamatergic transmission. Ampakines (CX614 and CX717) alleviated DAMGO-induced depression
of XII MN activity through postsynaptic actions on XII motoneurons.
Conclusions/Significance: The inspiratory-depressant actions of opioid analgesics include presynaptic inhibition of XII
motoneuron output. Ampakines counteract m-opioid receptor-mediated depression of XII motoneuron inspiratory activity.
These results suggest that ampakines may be beneficial in countering opiate-induced suppression of XII motoneuron
activity and resultant impairment of airway patency.
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Introduction
Respiratory depression induced by opioid analgesics is a
significant clinical problem [1]. This includes opiate-induced
depression of hypoglossal motoneuron (XII MN) output, which
activates the genioglossal muscle of the tongue and helps maintain
an open airspace for effective breathing [2,3]. Children and adults
with obstructive sleep apnea (OSA) are particularly prone to
opioid-induced apnea [4,5,6,7,8]. The mechanisms underlying
opioid-induced suppression of XII nerve activity [9] are not well
understood. Further, the current therapy to overcome the
respiratory depression of administering m-opiate receptor antag-
onists, such as naloxone, has the distinctly undesirable effect of
removing analgesia. However, recent work [10,11] has demon-
strated that positive modulators of the AMPA sub-type of
glutamate receptor, AMPAKINES, alleviate the opiate-induced
depression of central respiratory rhythmogenesis [9], which is
hypothesized to emanate from the preBo ¨tzinger complex (pre-
Bo ¨tC), without affecting analgesia. These data have led us to first
assess whether an opiate-mediated inhibition of XII MNs
contributes to the opiate-induced depression of breathing, and
second, to examine the utility of AMPAKINES in reversing the
opiate-mediated inhibition of XII inspiratory motor output.
AMPAKINES are a family of compounds that modulate the
actions of the excitatory neurotransmitter glutamate at AMPA
receptors by altering channel kinetics [12,13]. AMPA-receptor
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to XII MNs [14,15]. Thus, we hypothesized that increasing the
charge transfer of inspiratory drive currents with AMPAKINES
would counter m-opiate receptor-mediated suppression of XII MN
excitability. In this study we used medullary slice preparations
from neonatal rats that produce inspiratory-related output in vitro
to: i) determine the action of m-opioid receptor activation on XII
MN inspiratory activity; ii) determine the mechanism and sites of
actions of m-opioids within the XII motor nucleus, and iii) test the
hypothesis that AMPAKINES counter opioid-induced depression
of XII MN activity.
We examined the effects of two structurally distinct AMPA-
KINES, CX717 and CX614, which are classified as low- and
high-impact AMPAKINES, respectively, based on differences in
binding site, and the degree to which they modulate desensitiza-
tion, deactivation and channel open probability [16,17].
Methods
Medullary Slice and Extracellular Nerve Recordings
All experimental procedures were approved by University of
Alberta Faculty of Medicine Animal Welfare Committee (Edmon-
ton, AB). To examine the effects of [D-Ala(2),N-Me-Phe(4),-
Glyol(5)]-enkephalin (DAMGO) and AMPAKINE compounds on
XII MN activity, rhythmically-active medullary slices obtained
from neonatal (postnatal day 0 - 4, P0 - P4) Wistar rats were used.
Animals were anaesthetized through inhalation of isoflurane and
decerebrated. Rhythmic medullary slices were obtained by
previously described methods [18]. Briefly, the brainstem-spinal
cord was then isolated in cold, artificial cerebrospinal fluid (aCSF)
containing (mM): 120 NaCl, 3 KCl, 1.0 CaCl2, 2.0 MgSO4,2 6
NaHCO3, 1.25 NaH2PO4, 20 D-glucose, equilibrated with 95%
O2/5% CO2. The brainstem-spinal cord was pinned to a wax
chuck and serial 100–200 mm sections were cut in the rostral to
caudal direction using a vibratome (Leica VT1000S, Nussloch,
Germany). The 700 mm rhythmic slice extended from this rostral
margin to the obex caudally and contained the preBo ¨tC, rostral
ventral respiratory group, most of the XII motor nuclei and the
rostral XII nerve rootlets. Slices were placed caudal surface up in a
glass-bottomed recording chamber (500 mL) that was mounted on
an upright microscope (Zeiss Axioscope II FS). Slices were held in
place via nylon threads stretched over a platinum wire flattened
into a horseshoe shape, and were continuously perfused with
recirculating aCSF (flow rate ,2 mL/min) aerated with 5% CO2/
95% O2. At least 30 minutes prior to the start of data collection,
the concentration of K
+ in the aCSF was raised from 3 to 9 mM to
ensure the production of long-term, stable inspiratory-related
rhythm.
XII MN population activity was recorded from the medullary
slice preparation using glass suction electrodes (A-M Systems,
Carlsborg, WA) placed over the severed ends of XII nerve rootlets.
Signals were amplified (5000X), band pass filtered (100 Hz–
5 kHz), rectified, integrated (t=25 ms) and then saved to a
computer via a Digidata 1322 A/D board (sampling rate=2–
5 kHz, Axon instruments).
Whole-Cell Recording
A horizontal puller (Sutter P-97) was used to pull patch pipettes
(3–4.5 MV) from filamented borosilicate glass (Clark/WPI,
1.2 mm outside diameter). Patch pipettes were filled with
intracellular solution (ICS) containing (in mM): 1) 140 potassi-
um-gluconate, 5 KCl, 5 NaCl, 1 CaCl2, 1 MgCl2, 10 HEPES, 10
EGTA, and 1 glucose. The pH of the ICS was adjusted to 7.2–7.3
using KOH.
The XII nucleus was clearly discernable in the slice preparation
and whole cell recordings were obtained from inspiratory XII
MNs located within ,70 mm of the slice surface. Recordings were
established under direct visualization using a CCD camera (ICD-
47; Ikegami, Tokyo, Japan) and monitor attached to a Zeiss
Axioscope II FS upright microscope equipped for infra-red
differential interference contrast microscopy [19]. Whole-cell
signals (membrane current or voltage) were amplified and filtered
with a patch-clamp amplifier (2–5 kHz low-pass filter, Multiclamp
700A, Axon Instruments) and acquired with a 1322 A/D board
and pClamp 9.0 software. Signals were displayed on a computer
monitor and stored to computer hard disc. Off-line analysis of
whole-cell signals was performed using Clampfit software. Series
resistance (Rs) and whole-cell capacitance (Cm) were estimated as
done previously [20,21] using the Rs and Cm compensation
features of MultiClamp Commander software to manually correct
the current response to square-wave voltage pulses
(100 Hz,210 mV, 3 ms) under voltage-clamp conditions.
Drugs and Their Application
The following drugs were used: DAMGO, tetrodotoxin (TTX),
strychnine, bicuculline, (all from Tocris, Ellsville, MO), alpha-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA),
and glutamate (both from Sigma, St Louis, MO). The AMPA-
KINE compounds, CX614 and CX717, were provided by Cortex
Inc (Dr. Mark Varney CEO, Irvine CA). Stock solutions of
AMPAKINES were made in DMSO (final concentration of
DMSO #0.02% (bath application) or #0.4% (local application))
and frozen in aliquots. DMSO alone at these concentrations is
without effect on baseline inspiratory behaviour [21,22]. Stock
solutions of all other drugs were made in standard aCSF and
frozen in aliquots. The final concentration of K
+ in the drug
solutions was matched to that of the aCSF.
Drugs were either applied to the bath or locally applied with
microinjection from triple-barreled pipettes (tip diameter ,5–
6 mm per barrel O.D.) pulled from borosilicate glass capillaries
(World Precision Instruments, Sarasota, FL). For local microin-
jection, drug pipettes were placed under microscope visualization
so that the tip was just above the surface of the slice in the same
relative position for each neuron. Drug microinjections (,10 psi)
were controlled via a programmable stimulator (Master-8, AMPI
Instruments, Jerusalem, Israel) linked to a solenoid.
Data Analyses
In most cases data are reported as the mean value relative to
control 6 S. E. of the mean. For data sets that were normally
distributed (Kolmogorov-Smirnov test, GraphPad Prism 4.0),
differences between means were identified using the Student t-
test when only two groups were compared while a one-way
ANOVA with the Tukey Multiple Comparison post test was used
(GraphPad Prism 4.0) when more than two groups were
compared. The non-parametric Wilcoxon matched pairs test (for
two data groups) or Friedman test with Dunns post test (for greater
than two groups) (GraphPad Prism 4.0) were used to assess
differences between data sets that were not normally distributed.
Values of p,0.05 were assumed significant.
The effect of bath application of drugs on XII nerve inspiratory
output was assessed using Clampfit software to measure the
resulting average change in XII inspiratory burst amplitude, area,
duration and frequency during a two minute period 15 minutes
after the drug was applied to the bath. Baseline and threshold
levels for bursts were set using Clampfit software. Bursts were then
automatically detected so that amplitude, area, duration and
frequency were measured. The area of the burst was calculated for
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this period were then compared to the average values over the two
minute control period prior to drug application. Washout data
were obtained using the same method 30 minutes after the drug
washout began.
The effect on XII nerve inspiratory activity of locally applying
drugs was assessed by measuring the resulting change in XII
inspiratory burst amplitude, area, duration and frequency during
the two minutes following drug application. The average values for
this period were then compared to the average values over the two
minute control period prior to drug application. Washout data
were obtained by measuring average values over a two minute
period occurring 15 minutes after the termination of drug
application.
Drug-induced currents were measured by calculating the
difference between the control or baseline (measured between
inspiratory bursts) membrane current measured two minutes prior
to drug application, and the peak membrane current during the
two minute period following drug application. Drug-induced
changes in the input resistance (RN) of inspiratory XII MNs were
calculated based on current responses to voltage ramps (1.5 s
duration, from 290 to 240 mV) applied before, during and after
application of drug. Input resistance was estimated from the
inverse slope of the linear portion of the current-voltage (I/V)
relationship. The voltage-dependence and reversal potential of
drug-induced currents were calculated by subtracting control I/V
relationship from the I/V relationship obtained during the drug
application. The effect of drug on inspiratory synaptic currents in
XII MNs was also examined. The average amplitude and area of
inspiratory synaptic currents during the two minutes following
drug application were compared to those obtained for the control
period prior to drug application.
To examine whether a drug acted via pre- or postsynaptic
mechanisms to modulate the inspiratory output from XII MNs,
the effect of the drug on miniature excitatory postsynaptic currents
(EPSCs) that occur in the presence of tetrodotoxin (TTX, 1 mM),
strychnine (10 mM) and bicuculline (10 mM) (all bath applied) was
assessed. Membrane current was first recorded (5 kHz, Clampex)
for 10–15 minutes in control conditions. Drugs were then applied
to the bath and following a 15 minute ‘‘wash in’’ period
membrane current was recorded again for a minimum of
10 min during the application of the drug of interest. Washout
data was obtained similarly for a ,10 minute period occurring at
least 30 minutes after initiation of drug washout. On average we
sampled ,500 EPSCs during control and drug for each cell. Series
resistance was closely monitored throughout these recordings and
the MN was rejected if there was any change between control and
drug conditions. In each condition the frequency and amplitude of
EPSCs was measured using a custom designed template search
protocol (Clampfit software). The effect of the drug on these
parameters was determined by comparing cumulative frequency
histograms for changes in the average mEPSC frequency and
amplitude values between periods of control and drug application.
Results
Section A: Effects of DAMGO on XII Inspiratory Activity
A1) Bath application of DAMGO depresses inspiratory
activity in the medullary slice preparation. Application of
the m-opioid receptor agonist, DAMGO (500 nM, bath), to the in
vitro rhythmically-active medullary slice preparation caused a
profound depression of respiratory activity (Fig 1A). Recordings
from XII nerve rootlets showed that subsequent to the addition of
DAMGO, inspiratory burst frequency, amplitude, area and
duration decreased to 0.2660.04, 0.6360.9, 0.4660.08 and
0.4760.07 of control respectively (n=23, p,0.05, Fig 1B).
A2) Local application of DAMGO to the XII nucleus
reduces inspiratory burst amplitude. To establish whether
m-opioid receptor activation has a direct affect on inspiratory burst
amplitude, we locally applied DAMGO to the XII motor nucleus.
Local application of DAMGO (5 mM, 30s; n=5) to the XII
nucleus of medullary slice preparations significantly decreased
inspiratory motor output recorded from the XII nerve (Fig 2A and
B). The amplitude of inspiratory bursts decreased to 0.6160.08 of
control (p,0.001), inspiratory burst area decreased to 0.3660.08
of control (p,0.01), and inspiratory burst duration decreased to
0.5460.09 (p,0.01) of control (Fig 2B). These inhibitory actions
on burst amplitude gradually reversed with washout of DAMGO.
There was no change in inspiratory burst frequency (1.0760.01 of
control) following local DAMGO application in the XII nucleus.
Interestingly, local application of DAMGO (5 mM, 10s; n=10)
into the preBo ¨tC also reduced both inspiratory XII burst
amplitude and frequency to 0.8960.06 (p,0.05) and 0.6060.03
(p,0.001) of control respectively (Fig 2C and D). This is consistent
with the localization of XII preMNs adjacent (dorsal) to the
preBo ¨tC region [23].
Data from rat in vivo studies demonstrate that opiates can
depress XII MN activity in part via an increase in acetylcholine
release [24]. Thus, to assess whether the DAMGO-induced
depression of XII MN inspiratory activity was due to the activation
of muscarinic acetylcholine receptors, we locally-applied DAMGO
Figure 1. Bath application of DAMGO depresses inspiratory
activity. A) Integrated (#) XII nerve activity recorded from a medullary
slice preparation illustrating that bath application of DAMGO (500 nM)
depresses inspiratory activity. B) Group data (n=12) showing the effect
of bath-applied DAMGO (500 nM) on XII inspiratory burst frequency
amplitude, area and duration relative to control. * = significantly
different from control (p,0.05).
doi:10.1371/journal.pone.0008766.g001
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bath application of the general muscarinic receptor antagonist,
atropine (1 mM). Atropine, at concentrations that blocked the
response to locally-applied muscarine (100 mM, 30 s, n=4)
(Fig 3A), failed to block the DAMGO-evoked reduction in XII
nerve inspiratory burst amplitude (Fig 3B). Burst amplitude
decreased to 0.6060.06 and 0.6260.05 of control in DAMGO
and atropine respectively (Fig 3C, n=4).
A3) DAMGO reduces inspiratory synaptic current
amplitude but does not change the input resistance of XII
MNs. Having established that DAMGO depresses the
inspiratory motor output recorded from the XII nerve, the
mechanism underlying this effect was further examined with
whole-cell recordings. Only inspiratory XII MNs (i.e. those that
showed distinct, inward inspiratory synaptic currents in phase with
inspiratory bursts in the XII nerve) were examined in this study.
DAMGO (5 mM, 30 s) was locally applied to 9 inspiratory MNs
with an average RN of 86615 MV that received inspiratory
synaptic currents averaging -136635 pA. DAMGO significantly
reduced inspiratory synaptic current amplitude from -136635 pA
to -82615 pA (0.6760.05 of control, p,0.01; n=9) (Fig 4A and
B) and inspiratory burst area to 0.5660.04 of control (p,0.001:
n=9). Despite these effects on synaptic currents, DAMGO had no
effect on membrane current in XII inspiratory MNs at a holding
potential of 260 mV, or between 275 and 255 mV, as shown for
a single MN (Fig 4A and C). The average baseline current at a
holding potential of 260 mV was 2163633 pA during control
and 2164634 pA following DAMGO application (n=9).
DAMGO was also without effect on the RN of inspiratory XII
MNs. RN averaged 86615 MV in control and 85614 MV
following DAMGO application (n=9) (Fig 4C and D).
A4) DAMGO reduces the frequency of miniature EPSCs
recorded from XII inspiratory MNs. Given that DAMGO
had no noticeable effect on the membrane properties of XII MNs,
we next assessed whether the DAMGO-evoked reduction in
inspiratory burst amplitude reflected an action on glutamatergic
synaptic transmission at the pre-motor to XII MN synapse. The
effect of DAMGO on the frequency and amplitude of mini EPSCs
recorded from inspiratory XII MNs was assessed with whole-cell
recordings made in the presence of bath-applied TTX (1 mM),
strychnine (10 mM), and bicuculline (10 mM) to block action
potentials and GABA and glycinergic IPSCs, respectively.
DAMGO (500 nM, bath) significantly decreased the frequency
but not the amplitude of mini EPSCs (Fig 5A-D). The average
period (or inter event interval) of mini EPSCs increased from
300761081 ms to 602162019 ms (n=6, p,0.05) (Fig 5C). In
contrast, the amplitude of mini EPSCs was 22964 pA in control
and 22764 pA in DAMGO (n=6, Fig 5D). Washout data were
obtained for three of the six neurons. In this group of three MNs
the average period increased from 27816747 ms to
635461454 ms in DAMGO (p,0.01) and then recovered
partially to 408761557 ms following washout of DAMGO (data
not shown).
SECTION B: Effects of Ampakines on DAMGO-Induced
Depression of XII Inspiratory Activity
B1) The AMPAKINES CX614 and CX717 alleviate opioid-
induced inspiratory depression. Bath application of
DAMGO (500 nM) profoundly depresses inspiratory activity
recorded from the XII nerve (see A1 above). This depression of
XII nerve activity was significantly alleviated by bath application
of either CX614 or CX717 (Fig 6). In the CX614 (10–20 mM)
experiments (n=5), DAMGO reduced inspiratory burst
frequency, amplitude, area and duration to 0.3360.07,
0.5860.05, 0.2960.05, and 0.4160.04 of control, respectively.
At 10 mM CX614, inspiratory burst frequency, amplitude, area
Figure 2. Local application of DAMGO to the XII nucleus depresses inspiratory burst amplitude, area and duration. A) #XII nerve
activity recorded from a medullary slice preparation demonstrating that local application of DAMGO (5 mM, 30s) into the XII nucleus decreases
inspiratory burst amplitude. B) Group data (n=5) show that local application of DAMGO (5 mM, 30 s) significantly reduces XII inspiratory burst
amplitude, area and duration. C) #XII nerve activity recorded from a medullary slice preparation demonstrating that local application of DAMGO
(5 mM, 10s) into the preBo ¨tC decreases inspiratory burst amplitude and frequency. D) Group data (n=10) show that local application of DAMGO
(5 mM, 10 s) significantly reduces XII inspiratory burst amplitude and frequency. * = significantly different from control (p,0.05).
doi:10.1371/journal.pone.0008766.g002
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0.9360.05 of control respectively (Fig 6). Following an increase of
CX614 to 20 mM the values for inspiratory burst frequency,
amplitude, area and duration were 0.5960.04, 1.1160.08,
1.7660.22 and 1.5360.12 (Fig 6) of control, respectively. These
reflect significant 2.2460.71, 1.9360.15, 6.4960.80 and
3.7660.25-fold increases from the respective DAMGO values
(Fig 6, p,0.05).
In the CX717 experiments, DAMGO reduced inspiratory burst
frequency, amplitude, area and duration to 0.2560.12,
0.3660.18, 0.2760.14 and 0.3560.17 of control, respectively
(n=6). With the subsequent addition of CX717 (50 mM) to the
bath, inspiratory burst amplitude and duration recovered to
0.8360.8, and 0.7260.06 relative to control respectively. These
represented increases of 1.1960.05 and 1.1860.06 relative to
DAMGO values, respectively (p,0.05). Inspiratory frequency and
burst area increased numerically (frequency: 0.2560.12
(DAMGO) to 0.4660.13 (CX717), area: 0.2760.14 (DAMGO)
to 0.6660.1 (CX717), but these were not statistically significant.
When CX717 was applied at 100 mM, however, significant
recovery was observed in all parameters. Inspiratory frequency,
amplitude, area and duration increased to; 0.3660.05, 0.9260.08,
0.6660.17 and 0.6360.15 of control, respectively (Fig 6, p,0.05).
B2) Local application of CX614 and CX717 to the XII
nucleus increases inspiratory burst amplitude following
DAMGO-induced depression. Since bath application of
AMPAKINES following DAMGO depression increased
inspiratory burst amplitude as well as frequency, we
hypothesized that these compounds had a direct effect in the
XII nucleus to modulate amplitude. To test this we locally injected
CX614 or CX717 to the XII nucleus subsequent to depressing
inspiratory output by bath applying DAMGO (500 nM). In this
series of experiments bath application of DAMGO significantly
Figure 3. Muscarinic receptors do not contribute to the
DAMGO-evoked depression of XII inspiratory activity. A) #XII
nerve activity recorded from a medullary slice preparation illustrating
that local application of muscarine (100 mM, 30 s) into the XII motor
nucleus (top trace) evokes tonic discharge and increases inspiratory
burst amplitude and that this response is inhibited by atropine (bath,
1 mM, bottom trace.) B) #XII nerve activity recorded from the same slice
preparation as in (A) showing that the inhibition of XII inspiratory burst
amplitude evoked by local application of DAMGO (5 mM, 30 s) in the XII
nucleus (top and bottom traces) is not reduced by bath-applied
atropine (1 mM, bottom trace). C) Group data (n=4) showing that the
magnitude of DAMGO-mediated inhibition of XII inspiratory burst
amplitude is not affected by bath-applied atropine.
doi:10.1371/journal.pone.0008766.g003
Figure 4. Local application of DAMGO to XII MNs reduces
inspiratory synaptic current amplitude. A) #XII nerve activity and
voltage-clamp (Vhold=260 mV) recording of membrane current (Im)
from an inspiratory XII MN illustrating the response to locally-applied
DAMGO (5 mM, 30 s). B) Group data (n=9) show that locally-applied
DAMGO (5 mM, 30 s) significantly reduces the amplitude of inspiratory
synaptic currents. C) Whole-cell I/V relationships obtained before
(control) and during application of DAMGO application to an inspiratory
XII MN. Subtraction of the control I/V from that obtained in DAMGO
produces the I/V relationship for the DAMGO current (DAMGO –
control). D) Group data (n=9) showing that DAMGO had no effect on
the RN of inspiratory XII MNs. *=significantly different from control
(p,0.05). y=transients resulting from delivery of the I/V ramp.
doi:10.1371/journal.pone.0008766.g004
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duration recorded from the XII nerve to 0.7260.1, 0.3160.05,
0.560.09 and 0.660.08 relative to control, respectively (n=11).
Subsequently, local application of CX614 (200 mM, 60–120s) to
the XII nucleus in six of these experiments significantly increased
inspiratory burst amplitude, area and duration by 1.560.3,
2.660.8 and 1.560.4 fold relative to the level observed in
DAMGO, respectively (n=6: Fig 7A). There was no effect on
inspiratory frequency. Similarly in the second group of
experiments, local application of CX717 (2 mM, 120 s) to the
XII nucleus evoked a significant increase in XII nerve inspiratory
burst amplitude (by 1.560.1 fold relative to DAMGO: n=5)
without affecting inspiratory burst area, duration or frequency
(Fig 7B). Local application of CX717 in control conditions (i.e.
without prior initiation of an opioid-induced respiratory
depression) had no effect on the amplitude of inspiratory bursts
from the XII nerve (n=3, not shown). However, local application
of CX614 produced a small but significant increase in burst
amplitude (1.1260.04 fold greater than control, n=4, data not
shown).
B3) CX614 and CX717 increase XII MN inspiratory
synaptic current amplitude following DAMGO-induced
depression. The effect of AMPAKINES on XII MN
inspiratory synaptic currents was assessed using whole –cell
recordings from inspiratory XII MNs. Either CX614 (20 mM) or
CX717 (200 mM) was bath applied after inspiratory activity was
depressed with DAMGO (500 nM, bath). Bath-applied DAMGO
(n=15) significantly reduced inspiratory synaptic current
amplitude and area (charge transfer) to 0.760.03 and 0.660.04
of control, respectively (Fig 8A, B). Bath application of CX614 to
seven of these neurons significantly increased both peak amplitude
and charge transfer by 2.360.3 and 460.8 fold relative to
DAMGO, respectively (Fig 8A, B, n=7). Neither DAMGO nor
CX614 altered RN (1.1160.03 and 1.0660.06 relative to control,
respectively; data not shown). Bath application of CX717 to the
remaining eight neurons caused inspiratory synaptic current
amplitude to significantly increase by 1.560.1 fold relative to
DAMGO (p,0.05) (Fig 8C, D). Charge transfer did not
significantly increase from DAMGO levels, however, the charge
transfer value in CX717 was no longer significantly reduced
compared to control (p,0.05) (Fig 8C, D). Neither DAMGO nor
Figure 5. Bath application of DAMGO reduces the frequency of
mEPSCs in inspiratory XII MNs. A) Voltage-clamp (Vhold=260 mV)
recording of membrane current (Im) from an inspiratory XII MN in the
presence of TTX (1 mM), strychnine (10 mM) and bicuculline (10 mM)
before (right trace) and after (left trace) bath application of DAMGO
(500 nM). B) Cumulative frequency histogram for one XII MN showing
that DAMGO increased the inter-event interval of mEPSCs. C and D)
Group data (n=6) illustrate that DAMGO evokes a significant increase
in the mEPSC inter-event interval but not the mEPSC amplitude.
* = significantly different from control (p,0.05).
doi:10.1371/journal.pone.0008766.g005
Figure 6. Bath application of CX614 or CX717 counters
DAMGO-induced inspiratory depression. #XII nerve activity
recorded from a medullary slice preparation and group data illustrating
that the depression of respiratory activity evoked by bath-applied
DAMGO (500 nM) was significantly attenuated by bath application of
(A) CX614 (5–20 mM, n=5) or (B) CX717 (50–100 mM, n=6). Expanded
time scale excerpts from control, DAMGO and AMPAKINE conditions are
shown on the right hand side of the continuous time trace in (A) and
(B). * = significantly different from control, # = significantly different
from DAMGO (p,0.05).
doi:10.1371/journal.pone.0008766.g006
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PLoS ONE | www.plosone.org 6 January 2010 | Volume 5 | Issue 1 | e8766Figure 7. Local application of CX614 or CX717 to the XII nucleus counters DAMGO-induced depression of XII inspiratory burst
amplitude. #XII nerve activity from a medullary slice preparation and group data illustrating that the depression of inspiratory burst amplitude,
duration and area evoked by bath application of DAMGO (500 nM) was significantly reduced by local application of (A) CX614 (200 mM, n=6) or (B)
CX717 (2 mM, n=5) into the XII nucleus. # = significantly different from DAMGO (p,0.05).
doi:10.1371/journal.pone.0008766.g007
Figure 8. CX614 and CX717 potentiate XII MN inspiratory synaptic currents following a DAMGO-induced depression of inspiratory
activity. #XII nerve activity and voltage-clamp (Vhold=260 mV) recording of membrane current (Im) from an inspiratory XII MN illustrating the effects of
bath-applying first DAMGO (500 nM) and then (A) CX614 (20 mM) or (C) CX717 (200 mM). Middle traces show an inspiratory synaptic current envelope
averagedfromfiveinspiratorycyclesineachcondition.GroupdatashowingtheeffectsofDAMGOand,inthecontinuedpresenceofDAMGO,theeffectsof
CX614 (B, n=7) or CX717 (D, n=8) on the amplitude and area of inspiratory synaptic currents. # = significantly different from DAMGO (p,0.05).
doi:10.1371/journal.pone.0008766.g008
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(1.0760.02 and 1.0160.04 relative to control, respectively; data
not shown).
B4) Ampakines may act on XII inspiratory MNs through a
postsynaptic mechanism. Whole-cell recordings were used to
examine the effect of CX614 on AMPA receptor currents in
inspiratory XII MNs. Motoneurons were first identified as
inspiratory based on inward synaptic currents in phase with XII
bursts. Then, in the presence of TTX, we locally applied either
glutamate (200 mM, 200 ms, n=2) or AMPA (10 mM, 200 ms,
n=3) before, during and after bath application of CX614
(20 mM). Glutamate/AMPA receptor current amplitude, area
and duration reversibly increased by 2.2760.1, 4.3461.5 and
2.1260.75 fold, respectively, in the presence of CX614 (p,0.05,
n=5, Fig 9A, B).
To further investigate the mechanism underlying the CX614-
mediated enhancement of inspiratory burst activity, we examined
the effect of CX614 on mini EPSCs in XII inspiratory MNs. In the
presence of TTX (1 mM), bicuculline (10 mM), strychnine (10 mM)
and DAMGO (500 nM), bath application of CX614 (20 mM) had
no effect on the inter-event interval (385361068 ms to
23756498 ms) or amplitude (23766p At o23565 pA) of mini
EPSCs in inspiratory XII MNs (n=5, data not shown). However,
CX614 did significantly change the shape of the mini EPSCs by
slowing decay kinetics (Fig 9C and Table 1).
We also examined the effect of CX717 on AMPA receptor
currents in XII MNs. AMPA (10 mM, 400 ms, n=5) was locally
applied in the presence of TTX before, during and after bath
application of CX717 (200 mM). Although AMPA receptor
current amplitude was unaffected by CX717 (1.0860.07 relative
to control), current area (charge transfer) and duration increased
by 1.2360.1 and 1.2560.04 fold (p,0.05, n=5, Fig 10A, B).
The effect of CX717 on mini EPSCs in XII inspiratory MNs
was also examined in the presence of TTX (1 mM), bicuculline
(10 mM), strychnine (10 mM) and DAMGO (500 nM). Under
these conditions, bath application of CX717 (200 mM) had no
significant effect on either the inter-event interval (529663044 ms
vs. 439661739 ms) or amplitude (22864 pA vs. 22864 pA) of
mini EPSCs (n=5, data not shown). CX717 was also without
effect on the shape of the mini EPSCs (Fig 10C and Table 2).
Discussion
m-Opiate Receptor Effects on Inspiratory XII MN Activity
In this study we demonstrate that local application of DAMGO
into the XII nucleus depresses the output of inspiratory XII MNs
in neonatal preparations in vitro. These findings, which suggest
that m-opioid receptors are expressed within the XII nucleus and
activation of these receptors modulates the activity of inspiratory
XII MNs, are consistent with recent in vivo studies in adult rats
[2]. However, the expression of m-opioid receptors in the XII
motor nucleus and also the mechanism underlying modulation of
XII MNs by m-opioids is controversial. m-opioid receptor labeling
in the XII nuclei of adult rat [25] and cat [26] is relatively sparse.
In the adult cat none of the extremely few m-opioid-receptor
containing nerve processes found in the XII nucleus appear to
make contact with genioglossus MNs [26]. In addition, no m-
opioid receptors were found on the soma. Thus, it was
hypothesized that systemically administered morphine depresses
genioglossus muscle activity [27] through mechanisms that operate
outside the XII nucleus [26]. However, a different study found
strong expression of m-opioid receptors in the XII nucleus of
embryonic, neonatal and adult rat [28]. Our data demonstrates
both a direct action of m-opioid-receptors within the XII MN pool
Figure 9. CX614 acts postsynaptically to potentiate AMPA or glutamate-evoked currents in XII MNs. A) Voltage-clamp (Vhold=260 mV)
recording of membrane current (Im) from an inspiratory XII MN before (left most trace, note different amplitude scale) and during bath application of
TTX (1 mM). Brief pulses of AMPA or glutamate (indicated by short horizontal bar above current trace) were delivered before, during and after bath
application of CX614 (20 mM). B) Group data (n=5) showing the relative amplitude, area and duration of the AMPA/glutamate currents in control and
during CX614. C) Voltage-clamp (Vhold=260 mV) recording of membrane current (Im) from two different inspiratory XII MNs in the presence of TTX
(1 mM), strychnine (10 mM), bicuculline (10 mM) and DAMGO (500 nM) illustrating the effect of CX614 (bath, 20 mM) on the shape of the mEPSCs. Each
trace represents the average of 20–30 individual mEPSCs. * = significantly different from control (p,0.05).
doi:10.1371/journal.pone.0008766.g009
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preBo ¨tC that contains XII pre-MN [23] .
In other parts of the CNS, the inhibitory actions of m-opioid
receptor activation are mediated via G protein-regulated mech-
anisms at pre and/or postsynaptic membranes. Presynaptically, m-
opioid receptor activation diminishes Ca
2+-dependent,exocytotic
neurotransmitter release by inhibiting voltage-dependent Ca
2+-
channels, or by activating K
+ channels, which raises the threshold
and shortens the duration of action potentials [29,30]. Postsynap-
tically, m-opioid agonists activate at least two different K
+
conductances, one of which is an inward rectifier [31]. Data from
our study suggest that the DAMGO-induced depression of XII
MN activity results from presynaptic modulation of glutamatergic
transmission. This is supported by the observation that DAMGO,
whether locally- or bath-applied, had no effect on XII MN
membrane current or resistance, whereas it affects both param-
eters in m-opioid receptor expressing rhythmogenic preBo ¨tC
neurons [32]. In addition, DAMGO decreased the frequency,
but not the amplitude, of miniature EPSCs.
The m-opioid receptor-mediated depression of XII MN
inspiratory output is hypothesized to involve ACh release and
the subsequent presynaptic inhibition of glutamatergic transmis-
sion through activation of muscarinic receptors [24], however, this
finding is controversial [2]. Our data in the neonatal rat medullary
slice preparation suggest that activation of muscarinic receptors in
the XII nucleus is excitatory. In addition, the DAMGO-mediated
inhibition of XII inspiratory output in neonates in vitro was
completely unaffected by blocking muscarinic receptors. While this
discrepancy may reflect preparation differences (in vitro versus in
vivo), it is more likely to reflect a developmental change in
muscarinic modulation. As seen in our experiments, previous work
in neonatal rats in vitro indicates that activation of mACh
receptors on XII MNs causes depolarization, facilitates repetitive
firing and potentiates XII inspiratory burst output [33,34]. In
contrast, activation of mACh receptors suppresses the activity of
juvenile XII MNs in vitro, via presynaptic inhibition of evoked
glutamatergic excitatory inputs [35]. This development change is
consistent with the observation in adult rat that mAChR activation
suppresses inspiratory-related activity of the genioglossus muscle
[36].
Effect of Ampakines
The high- (CX614) and low-impact (CX717) AMPAKINES
both alleviated the DAMGO-induced depression of XII MN
activity and inspiratory synaptic drive in a dose-dependent
manner. Importantly, the effect of AMPAKINES was not
restricted to the preBo ¨tC where the rhythmic drive is generated,
because local application of AMPAKINES to the XII nucleus
alone increased XII MN output following DAMGO-mediated
depression. In addition, both AMPAKINES had postsynaptic
actions on XII MNs. CX614 was particularly potent at increasing
the amplitude, duration and area of postsynaptic currents induced
Table 1. Effects of CX614 on mEPSC kinetics.
control (DAMGO) CX614
Mean 6 SEM Mean 6 SEM
Time to Rise Half-amplitude (ms) 0.7560.02 0.8160.03
Time to Decay Half-amplitude (ms) 6.3260.11 6.66*60.15
Decay Tau (ms) 3.3760.14 3.9*60.2
Max Rise Slope (pA/ms) 24267 23867
Max Decay Slope (pA/ms) 5.9561.01 5.1861.07
Rise Slope 10% to 90% (pA/ms) 222.563.91 219.664.08
Decay Slope 90% to 10% (pA/ms) 5.5160.85 4.7460.84
Rise Time 10% to 90% (ms) 1.3760.02 1.43*60,03
Decay Time 90% to 10% (ms) 5.070.3 5.2460.12
*= significantly different from control (DAMGO) (p,0.05).
doi:10.1371/journal.pone.0008766.t001
Figure 10. CX717 acts postsynaptically to potentiate AMPA or glutamate-evoked currents in XII MNs. A) Voltage-clamp
(Vhold=260 mV) recording of membrane current (Im) from an inspiratory XII MN during bath application of TTX (1 mM). Brief pulses of AMPA
(indicated by short horizontal bar above current trace) were delivered before, during and after bath application of CX717 (200 mM). B) Group data
(n=5) showing the relative amplitude, area and duration of the AMPA currents in control and during CX717. C) Voltage-clamp (Vhold=260 mV)
recording of membrane current (Im) from an inspiratory XII MN in the presence of TTX (1 mM), strychnine (10 mM), bicuculline (10 mM) and DAMGO
(500 nM) illustrating the shape of the mEPSC in control (DAMGO) and CX717 (bath, 200 mm). Each trace represents the average of 20–30 individual
mEPSCs. * = significantly different from control (p,0.05).
doi:10.1371/journal.pone.0008766.g010
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the decay of mini EPSCs. These actions at inspiratory XII MN
synapses are consistent with those cyclothiazide, which also
inhibits AMPA receptor desensitization and slows deactivation
[22] They are also consistent with those reported for AMPA/
glutamate currents in hippocampal slices [37], and for the high-
impact AMPAKINES in general which potently slow the kinetics
of both channel closing and desensitization.
The effects of CX717 on XII MN responses were more subtle
than those of CX614. CX717 increased the duration and area, but
not the amplitude, of currents induced by exogenous AMPA/
glutamate. The mechanisms by which CX717 and other low-
impact AMPAKINES produce their actions are less well
understood than for high impact AMPAKINES. They do not
strongly modulate EPSC amplitude but rather cause slight changes
in channel opening probability and open time [17,38,39,40].
These changes can be difficult to detect in an EPSC averaged from
many events at multiple unidentified synapses as done here, and
this may contribute to the fact that the effect of CX717 on mini
EPSCs did not reach statistical significance.
In addition to their direct effects on glutamatergic signaling,
high impact AMPAKINES such as CX614 elevate the neuronal
production of BDNF [41]. However, any actions via BDNF-
mediated mechanisms are unlikely to play a role in the responses
of XII MN measured in this study as the rapid kinetics of CX614
effects is inconsistent with an up-regulation of BDNF synthesis.
It is noteworthy that CX717 did not potentiate baseline XII
MN nerve discharge and the only effect of CX614 on baseline
activity was a small but significant increase in burst amplitude.
Therefore, stimulatory effects of AMPAKINES were considerably
more apparent following DAMGO-induced depression of XII MN
activity. This is consistent with observations in vitro and in vivo
that AMPAKINES only increase respiratory frequency after it is
suppressed by opioid administration [11,42]. Similarly, CX717
does not elevate respiratory or cardiovascular parameters under
baseline conditions in human studies [43,44,45]. The mechanism
underlying the preferential potentiation of suppressed synapses or
networks by AMPAKINES is not fully understood [16,46], but of
obvious significance from a therapeutic perspective in that it will
reduce the likelihood of side-effects. This is especially true for
CX717 (and possibly all low-impact AMPAKINES), in that not
only are its actions limited to depressed glutamatergic synapses, its
potentiation of the depressed activity never exceeded baseline
values (i.e. those that preceded DAMGO). CX614 similarly acted
only on suppressed synapses. However, this high impact
AMPAKINE elevated the burst envelope and synaptic currents
to levels that exceeded baseline.
In summary, these data demonstrate that the marked
suppression of XII MN inspiratory discharge by m-opiate receptor
agonists, which is primarily attributed to their actions at the level
of the preBo ¨tC or premotor networks [47], is also due to direct
actions at the glutamatergic, premotor-to-XII MN inspiratory
synapse. More specifically, m-opiate receptor agonists inhibit
glutamate release from presynaptic terminals onto XII MNs.
Data also demonstrate that AMPAKINES alleviate the opiate-
induced depression of breathing and that this occurs in part
through the modulation of AMPA receptors at XII MN synapses.
Importantly, low-impact AMPAKINES are metabolically stable,
do not cause unwanted side-effects and do not interfere with
analgesia [11]. Thus, they hold promise as a potential pharma-
cological therapy to treat opiate-induced suppression of XII MN
activity and the resultant loss of airway patency. It will be
interesting to explore the utility of AMPAKINES in counteracting
the depression of XII MN activity that contributes to other
pathological conditions such as apnea of prematurity, obstructive
sleep apnea and opioid-induced central apnea.
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